Preliminary results from a phase II study of the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in patients > 70 years of age with previously untreated advanced non-small cell lung carcinoma

Kinase Inhibitor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Preliminary results from a phase II study of the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in patients > 70 years of age with previously untreated advanced non-small cell lung carcinoma

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7080 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7080-7080 ◽

Cited By ~ 2

Author(s):

B. E. Johnson ◽

J. Lucca ◽

M. S. Rabin ◽

T. J. Lynch ◽

P. Ostler ◽

...

Keyword(s):

Kinase Inhibitor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Interstitial Lung Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Carcinoma

Clinical Lung Cancer ◽

10.3816/clc.2006.s.011 ◽

2006 ◽

Vol 8 ◽

pp. S31-S35 ◽

Cited By ~ 15

Author(s):

Ken Y. Yoneda ◽

Kimberly A. Hardin ◽

David R. Gandara ◽

David K. Shelton

Keyword(s):

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Tyrosine Kinase Inhibitor Therapy ◽

Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor

Thoracic Cancer ◽

10.1111/1759-7714.12217 ◽

2014 ◽

Vol 6 (6) ◽

pp. 800-804 ◽

Cited By ~ 16

Author(s):

Woo-Jin Kim ◽

Sunmin Kim ◽

Hayoung Choi ◽

Jinsun Chang ◽

Hong-Joon Shin ◽

...

Keyword(s):

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Histological Transformation ◽

Genetic alterations in epidermal growth factor receptor‑tyrosine kinase inhibitor‑na�ve non‑small cell lung carcinoma

Oncology Letters ◽

10.3892/ol.2020.11524 ◽

2020 ◽

Author(s):

Takumi Yamaura ◽

Satoshi Muto ◽

Hayato Mine ◽

Hironori Takagi ◽

Masayuki Watanabe ◽

...

Keyword(s):

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Genetic Alterations ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Cancer Research and Treatment ◽

10.4143/crt.2013.45.2.79 ◽

2013 ◽

Vol 45 (2) ◽

pp. 79-85 ◽

Cited By ~ 15

Author(s):

Jae Cheol Lee ◽

Seung Hun Jang ◽

Kye Young Lee ◽

Young-Chul Kim

Keyword(s):

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Epidermal Growth Factor Receptor Tyrosine Kinase: A Potential Target in Treatment of Non-Small-Cell Lung Carcinoma

Journal of Environmental Pathology Toxicology and Oncology ◽

10.1615/jenvironpatholtoxicoloncol.2017018341 ◽

2017 ◽

Vol 36 (2) ◽

pp. 151-158 ◽

Cited By ~ 8

Author(s):

Venugopal Vinod Prabhu ◽

Niranjali Devaraj

Keyword(s):

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Epidermal Growth ◽

Kinase A

Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181cf0440 ◽

2010 ◽

Vol 5 (4) ◽

pp. 491-496 ◽

Cited By ~ 29

Author(s):

Emilie Pluquet ◽

Jacques Cadranel ◽

Anne Legendre ◽

Michelle Beau Faller ◽

Pierre Jean Souquet ◽

...

Keyword(s):

Kinase Inhibitors ◽

Receptor Tyrosine Kinase Inhibitors

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Epidermal Growth ◽

190TiP: ELUXA 1: Phase II study of BI 1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(16)30299-4 ◽

2016 ◽

Vol 11 (4) ◽

pp. S139 ◽

Cited By ~ 11

Author(s):

K. Park ◽

J.-Y. Han ◽

D.-W. Kim ◽

L.A. Bazhenova ◽

S.-H. Ou ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tki

Abstract A25: Uncommon mutation types of Epidermal Growth Factor Receptor (EGFR) and tyrosine kinase inhibitor response in non-small cell lung carcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.mechres-a25 ◽

2012 ◽

Vol 18 (10 Supplement) ◽

pp. A25-A25 ◽

Cited By ~ 1

Author(s):

Maria P. Wong ◽

Victor H.F. Lee ◽

Rebecca M.W. Yeung ◽

Vicky P.C. Tin ◽

Kit Chi Choy ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Outcomes of sequential epidermal growth factor receptor tyrosine (EGFR) tyrosine kinase inhibitor (TKI) therapy in patients with advanced non-small cell lung carcinoma (NSCLC)- a real-world institutional experience

Annals of Oncology ◽

10.1093/annonc/mdz437.016 ◽

2019 ◽

Vol 30 ◽

pp. ix165-ix166

Author(s):

Y. Ang ◽

R. Wong ◽

C.S. Tan ◽

M.V. Blanco ◽

Y. Huang ◽

...

Keyword(s):

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Cell Lung Carcinoma ◽

Institutional Experience ◽